Interestingly, we found that low pre-conditioning serum Leptin predicts early relapse in AML patients of intermediate or advanced stages, i.e., in those patients who have relapsed after previous lines of treatment or those who failed to achieve remission before transplantation. Here, LEP is linked to acute myeloid leukemia.